ABSTRACT
The analysis of "Survey Participation in the Time of Corona" is replicated by taking a more recent survey into account that was conducted one year later during the same period. The results clearly indicate that the temporary public shutdown in spring 2020 indeed boosted the panellists’ participation at the initial stage of the survey. © 2022Author(s).
ABSTRACT
The singular effect of a public shutdown in spring 2020—as a result of non-pharmaceutical official orders and arrangements in the course of the COVID-19 pandemic—on survey participation is investigated. The analysis is focused on panellists born around 1997 and living in German-speaking cantons of Switzerland. Utilising the techniques and procedures of event history analysis, the paradata of the fieldwork period are analysed in a dynamic micro–macro design. Several competing time-varying effects on the panellists’ survey participation and changes in the pandemic progress are controlled for, in addition to time-constant covariates, such as their education and social origin. Indeed, it becomes obvious that the public shutdown during the first wave of the pandemic improved the target persons’ propensity for survey participation. © 2022Author(s).
ABSTRACT
ProtonDx will provide a response to the COVID-19 pandemic by bringing nucleic-acid based molecular diagnostics to the palm of your hand. It will support the deployment of the Lacewing technology, which achieves accurate, rapid, handheld and low cost detection of SARS-CoV-2 and other respiratory infections. Results are synchronized to electronic health records and geotagged for real-time surveillance of disease progression. The device was designed for use at the point of need, in places such as pharmacies, schools and workplaces. Its unique approach combines standard semiconductor technology, advanced molecular biology and 3D printed microfluidics to match the performance of a bench-based instrument. Clinical trials are currently in progress at Imperial NHS Trust, London, UK which will lead to regulatory approvals and commercialization in the next few months. © 2001-2012 IEEE.